clinical effectiveness of biophosphates.pdf (491.4 kB)
Download fileClinical effectiveness of bisphosphonates for prevention of fragility fractures: a systematic review and network meta-analysis
poster
posted on 2020-03-09, 16:20 authored by Jean SandersonJean Sanderson, Marrissa Martyn-St James, Sarah DaviesSarah Davies, John Stevens, Edward Goka, Susie SadlerBACKGROUND
Osteoporosis is characterised by low bone mass and structural
deterioration of bone tissue, with a consequent increase in
susceptibility to fragility fracture. Fractures cause significant pain,
disability and loss of independence and can be fatal.
[1]
OBJECTIVE
To assess the relative efficacy of bisphosphonates (alendronate,
risedronate, ibandronate and zoledronate) for the treatment of
Osteoporosis using a network meta-analysis (NMA).
History
Ethics
There is no personal data or any that requires ethical approvalPolicy
The data complies with the institution and funders' policies on access and sharingSharing and access restrictions
The data can be shared openlyData description
- The file formats are open or commonly used
Methodology, headings and units
- Headings and units are explained in the files